Medications for Malignant Neoplasm Of Breast

14 results

  • arimidex - anastrozole tablet

    (Anastrozole)
    Ani Pharmaceuticals, Inc.
    Arimidex is an aromatase inhibitor for postmenopausal women with breast cancer: adjuvant treatment of hormone receptor-positive early breast cancer; first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer; and second-line treatment of advanced breast cancer following tamoxifen therapy progression.
    Medication Details
    Drug Interactions

  • aromasin - exemestane tablet

    (Exemestane)
    Pharmacia & Upjohn Company Llc
    Aromasin treats estrogen-receptor positive early breast cancer in postmenopausal women switching from tamoxifen to complete five years of adjuvant hormonal therapy. Also indicated for advanced breast cancer in postmenopausal women whose disease has progressed after tamoxifen therapy.
    Medication Details
    Drug Interactions

  • halaven - eribulin mesylate injection

    (Eribulin Mesylate)
    Eisai Inc.
    HALAVEN treats metastatic breast cancer in patients who have received at least two prior chemotherapy regimens including an anthracycline and taxane, and unresectable or metastatic liposarcoma in patients who have received a prior anthracycline-containing regimen.
    Medication Details
    Drug Interactions

  • herceptin - trastuzumab injection, powder, lyophilized, for solution

    (Trastuzumab)
    Genentech, Inc.
    Herceptin treats HER2-overexpressing breast cancer (adjuvant and metastatic) and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma in adults. Used in combination chemotherapy regimens or as a single agent. Requires FDA-approved companion diagnostic for patient selection.
    Medication Details
    Drug Interactions

  • herceptin hylecta - trastuzumab and hyaluronidase - oysk injection, solution

    (Trastuzumab And Hyaluronidase-Oysk)
    Genentech, Inc.
    Herceptin Hylecta (trastuzumab/hyaluronidase) treats HER2-overexpressing breast cancer in adults. Indicated for adjuvant treatment of node-positive or high-risk node-negative breast cancer, and for metastatic breast cancer — first-line with paclitaxel or as a single agent after prior chemotherapy.
    Medication Details
    Drug Interactions

  • ibrance - palbociclib capsule

    (Palbociclib)
    Pfizer Laboratories Div Pfizer Inc
    IBRANCE treats HR-positive, HER2-negative advanced or metastatic breast cancer in adults, combined with an aromatase inhibitor or fulvestrant. Also indicated with inavolisib and fulvestrant for endocrine-resistant, PIK3CA-mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer after adjuvant endocrine therapy.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • kisqali - ribociclib tablet, film coated

    (Ribociclib)
    Novartis Pharmaceuticals Corporation
    Kisqali treats HR-positive, HER2-negative breast cancer in adults. Used with an aromatase inhibitor for early-stage (II–III) breast cancer at high recurrence risk, and for advanced or metastatic disease with an aromatase inhibitor or fulvestrant as initial or subsequent endocrine therapy.
    Medication Details
    Drug Interactions

  • lynparza - olaparib tablet, film coated

    (Olaparib)
    Astrazeneca Pharmaceuticals Lp
    Lynparza is a PARP inhibitor for adults with BRCA- or HRR-mutated cancers. Indicated for maintenance of ovarian cancer, adjuvant and metastatic breast cancer, maintenance of metastatic pancreatic cancer, and metastatic castration-resistant prostate cancer. Patient selection requires an FDA-approved companion diagnostic.
    Medication Details
    Drug Interactions